Fagron Compounding Services: Vancomycin Hci, 1.25 Grams Added To

Vancomycin HCI Recall Summary Fagron Compounding Services is recalling Vancomycin HCI 1.25 grams in 250 mL sodium chloride injection nationwide because the product cannot be assured to be sterile and because a blue piece of the administration port could potentially detach. This is a Class II recall, meaning the product could cause serious health problems or death. The recalled medication was distributed across all U.S. states and Washington, D.C.

Recalling firm

Fagron Compounding Services

Product

Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01

Reason

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-03-20

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the U.S.A.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/18ee1236-3861-40a5-ae1c-c601f9d96fad